Gene and MHC-II Variants as Risk Factors for the Development of Inhibitory Anti-Factor VIII Antibodies during the Treatment of Hemophilia A: A Computational Assessment.
Gouri Shankar PandeyChen YanoverTom E. HowardZuben E. SaunaPublished in: PLoS Comput. Biol. (2013)